«ΨΥΧΟΛΟΓΙΑ έρευνα & εφαρμογές» Τόμος 1, Τεύχος 3, 2018 ISSN: 2623-3673
Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med 2005; 352(6): 596–
607
Sata M, Fukuizumi K, Uchimura Y, Nakano H, Ishii K, Kumashiro R, Mizokami M, Lau
JY, Tanikawa K. Hepatitis C virus infection in patients with clinically diagnosed
alcoholic liver diseases. J Viral Hepat 1996; 3: 143–148
Schiff ER, Ozden N. Hepatitis C and alcohol. Alcohol Res Health 2003; 27: 232–239
Serfaty L, Poujol-Robert A, Carbonell N, Chazouilleres O, Poupon RE, Poupon R.
Effect of the interaction between steatosis and alcohol intake on liver fibrosis
progression in chronic hepatitis C. Am J Gastroenterol 2002; 97: 1807–1812
Serra MA, Escudero A, Rodriguez F, del Olmo JA, Rodrigo JM. Effect of hepatitis C
virus infection and abstinence from alcohol on survival in patients with alcoholic
cirrhosis. J Clin Gastroenterol 2003; 36: 170–174
Setshedi M, Wands JR, Monte SM. Acetaldehyde adducts in alcoholic liver disease.
Oxid Med Cell Longev 2010; 3(3): 178–185
Sherman D, Koskinas J, Williams R. Alcohol and the Liver. In: Peters TJ (ed). Alcohol
Misuse - A European Perspective. Harwood Academic Publishers, 1996, pp. 66-79
Shimizu S, Kiyosawa K, Sodeyama T, Tanaka E, Nakano M. High prevalence of
antibody to hepatitis C virus in heavy drinkers with chronic liver diseases in Japan. J
Gastroenterol Hepatol 1992; 7: 30–35
Shukla SD, Lim RW. Epigenetic effects of ethanol on the liver and gastrointestinal
system. Alcohol Res 2013; 35(1): 47–55
Shukla SD, Pruett SB, Szabo G, Arteel GE. Binge ethanol and liver: new molecular
developments. Alcohol Clin Exp Res 2013; 37(4): 550–557